Microsatellite Instability (MSI)
Microsatellite instability, colon cancer, KEYTRUDA® (pembrolizumab), PCC Screen, MSI Testing
Test Codes
EPIC: LAB3001
Department
Molecular Pathology
Specimen Collection Criteria
Collect:
Abnormal Tissue: 10% Formalin-fixed, paraffin-embedded tumor block with corresponding H&E slides. Tissue should be well fixed and well processed. Average tissue size 5.0 mm2.
Normal Tissue: 10% Formalin-fixed, paraffin-embedded normal tissue block with corresponding H&E slides. Tissue should be well fixed and well processed. Average tissue size 5.0 mm2. A fresh Peripheral Blood EDTA specimen will be accepted when a normal tissue block is unavailable.
- The specimen must be accompanied by a completed requisition and must contain the patient name, date of birth, collection date, ordering physician, and source of specimen.
Physician Office/Draw Specimen Preparation
Maintain paraffin-embedded tissue at room temperature (20-26°C or 68-78.8°F) until transport.
Preparation for Courier Transport
Transport: Paraffin-embedded tissue, at room temperature (20-26°C or 68-78.8°F).
Rejection Criteria
- Tissue treated with decalcifying agents other than Mol Decal (EDTA).
- Fixatives other than 10% neutral buffered formalin.
- Specimens fixed/processed in alternative fixatives (e.g., alcohol, zinc formalin).
- Improper labeling or inadequate information.
- Less than 10 percent tumor cellularity, at discretion of medical director.
- Poor quality and/or quantity of extracted genomic DNA.
Testing will be cancelled on specimens meeting the above criteria with client notification.
Inpatient Specimen Preparation
Specimens at Royal Oak may be sent to the Surgical Pathology tube station, #201. In-house specimens are also picked up by a Surgical Pathology assistant every hour on the hour.
In-Lab Processing
Unstained sections of 5-µm thickness are cut from selected tissue blocks. The number of sections cut and the need for macro-dissection are determined by the pathologist, based upon the amount of available tissue and the tumor cellularity.
Maintain specimens at room temperature (20-26°C or 68-78.8°F) until testing.
Storage
Specimen Stability for Testing:
Paraffin-embedded Abnormal and Normal Tissue:
Room Temperature (20-26°C or 68-78.8°F): Indefinitely
Refrigerated (2-8°C or 36-46°F): Unacceptable
Frozen (-20°C/-4°F or below): Unacceptable
Peripheral Blood EDTA:
Room Temperature (20-26°C or 68-78.8°F): 72 hours
Refrigerated (2-8°C or 36-46°F): 72 hours
Specimen Storage in Department Prior to Disposal:
Room Temperature (20-26°C or 68-78.8°F): 7 days
Specimen Storage (DNA post testing):
Frozen (-70 to -80°C): Indefinitely
Laboratory
Royal Oak Molecular Pathology Laboratory
Performed
As received. Test run once per week.
Results available in 7-10 business days.
Reference Range
Microsatellite stable tumor. Results obtained with tumor DNA are compared with results obtained with the patient's normal DNA.
Test Methodology
DNA is extracted from the tissue. Primers to six NCI consensus microsatellites are used to amplify both tumor and normal DNA. Fluorescently labeled products are analyzed by capillary electrophoresis.
Interpretation
Microsatellite stable, unstable-low (1 unstable locus), unstable-high (2 or more unstable loci).
Clinical Utility
Detects instability of microsatellite loci associated with a loss or suppression of DNA mismatch repair complex. In colorectal and endometrial adenocarcinoma, microsatellite unstable-high (MSI-H) status can correspond with both sporadic and inherited (i.e., Lynch Syndrome) microsatellite instability, as well as having prognostic implications. However, this assay cannot distinguish between sporadic and germline causes of MSI-H.
Pembrolizumab (Keytruda) is FDA-approved and NCCN guideline-recommended for use in any MSI-H solid tumor that is unresectable or metastatic.
CPT Codes
81301
Contacts
Molecular Pathology Lab – RO
248-551-0073
Name: Molecular Pathology Lab – RO
Location:
Phone: 248-551-0073
Last Updated
8/19/2024
Microtainer® and Vacutainer® are registered trademarks of Becton, Dickinson and Company.
UroVysion® is a registered trademark of Abbott Laboratories. ThinPrep® is a registered trademark of Hologic, Incorporated.